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Recent years were associated with substantial development of enteral nutrition, and particularly, home enteral nutrition (HEN) \[[@CR14]\]. For the last ten to 20 years, HEN has been fully reimbursed in many European countries which has contributed to increased popularity of this treatment modality \[[@CR8], [@CR13]\]. Also, in Poland, HEN has been developed and is reimbursed by the National Health Fund (NHF) since 2007. According to the regulations of NHF, however, enteral feeding is reimbursed only if there is no possibility of oral nutrition, which excludes oral supplementation or sip feeding included in the ESPEN definition of enteral feeding \[[@CR11]\].

Enteral nutrition is required in all patients who are unable to cover their energetic and nutritional requirements by means of normal ingestion despite, at least partially, retained function of the gastrointestinal tract. Potential advantages of HEN in comparison to traditional hospital-based enteral nutrition include shorter hospitalization, lower direct costs of therapy and lower risk of secondary malnutrition-associated complications.

According to sparse literature data, children constitute a minority among patients receiving HEN \[[@CR15]\]. Published epidemiologic data on the administration rates of enteral/parenteral home nutrition is very limited and available only in a few countries \[[@CR2], [@CR3], [@CR9], [@CR15]\]. In turn, reliable data on the administration rates of HEN is required to assess potential benefits associated with this treatment modality along with types and rates of associated complications. Additionally, it can be helpful in confronting requirements for this type of procedure with available resources. Finally, actual data is necessary for planning prospective studies of therapeutic outcomes of enteral nutrition. Constantly updated registries constitute the most optimal source of reliable data on HEN service availability and utilization rates. Despite their obvious advantages, only a few such national registries exist, however \[[@CR2], [@CR3], [@CR7], [@CR15]\].

Since it was reimbursed and thus available, the dynamic increase in the number of patients who were offered HEN services by Polish medical centers was observed during recent years. However, still there are some regions with no specialized centers offering HEN services for children. Therefore, the aim of this first nationwide study was to assess the availability of pediatric HEN services in Poland in order to identify potential areas that should be improved.

Materials and methods {#Sec2}
=====================

This study was based on a retrospective 1-year analysis of HEN services that were offered to Polish children in 2010. All public healthcare services in Poland are covered by the regional branches of the same funder, National Health Fund. Therefore, all 16 Polish provinces have the same HEN reimbursement criteria and procedures. According to these regulations, each healthcare provider is responsible for qualifying patients to nutritional treatment, training patients (or their parents---in the case of underage subjects) in HEN procedures, providing diets and all related devices, follow-up visits and all other necessary medical services.

In January 2010, the questionnaire, developed by the Polish Society for Clinical Nutrition of Children and previously tested for reliability and validity, was sent to all regional centers providing pediatric HEN services in Poland (*n* = 14). In each center, one person was assigned the responsibility of data collection. All participating centers returned completed questionnaires between January and March of 2011.

The results of the survey were analyzed with an aid of Statistica 8 (StatSoft®) package. The analysis included the number of pediatric patients who received HEN on January 1st 2010 and December 31st 2010, their demographic characteristics and geographical distribution. The prevalence rate of HEN was expressed as the number of children receiving this type of service per one 1 million of the inhabitants in the analyzed region. Furthermore, the distributions of indications and methods of enteral nutrition administration were analyzed, along with the potential reasons of withdrawal from the HEN program.

Results {#Sec3}
=======

The number of children receiving HEN in 2010 increased by 21% (from 433 to 525 patients) compared to January 1st 2010. Within the study period, 73 patients were withdrawn from the HEN program due to various reasons (Table [1](#Tab1){ref-type="table"}), and 165 new subjects were qualified to the enteral feeding (31.43%).Table 1Exclusion criteria from polish pediatric HEN program in 2010CriterionNumberLack of satisfactory outcome1Complications associated with enteral nutrition2Lack of patient's acceptance7Lack of caregivers' acceptance7Satisfactory weight gain20Patient's death17Other19Total73

The fraction of children receiving HEN increased substantially in 2010, from 11.34 per 1 million inhabitants on January 1st to 13.75 per 1 million on December 31st. Marked differences were observed in terms of geographical distribution of this parameter, from zero (in two provinces) to up to 30 pediatric patients per 1 million inhabitants (Fig. [1](#Fig1){ref-type="fig"}).Fig. 1Geographic distribution of polish children receiving HEN in 2010

Most patients receiving HEN (*n* = 419, 79.8%) were supervised by specialized pediatric centers, while the remainder (*n* = 106, 20.2%) were handled by medical centers serving both children and adults.

Median age of patients receiving HEN in 2010 was 6 years (range: 9 months--18 years). This group included 247 girls (47.5%) and 278 boys (52.5%). In most cases, HEN was prescribed due to neurological disorders (*n* = 337, 64.2%). Other indications for HEN are summarized in Table [2](#Tab2){ref-type="table"}. In most cases (*n* = 450, 85.71%), enteral nutrition was administered by means of gastrostomy (Table [3](#Tab3){ref-type="table"}).Table 2Indications for enteral nutrition in polish children receiving HEN in 2010IndicationNumberPercentageCerebral palsy16431.2Encephalopathy529.9Spinal muscular atrophy (SMA)448.4Muscular dystrophy61.1Other neurological disorders7113.5Genetic syndromes9317.7Short bowel syndrome10.2Inflammatory bowel disease30.6Other gastrointestinal diseases265.0Cystic fibrosis203.8Chronic renal failure152.9Chronic liver failure10.2Oncological diseases51.0Malformation syndrome112.1Congenital heart disease40.8Metabolic disorders91.7Total525100.0Table 3Methods of enteral nutrition administration in polish children receiving HEN in 2010MethodNumberPercentageNasogastric tube5911.2Gastrostomy45085.7Nasojejunal tube20.4Jejunostomy40.8Gastrojejunal tube101.90Total525100.0

Discussion {#Sec4}
==========

This first Polish nationwide survey on HEN prevalence rates among pediatric patients included data from all centers offering this type of specialized services. Throughout 2010, a substantial increase was observed in the number of HEN-receiving children. Nonetheless, the fraction of Polish pediatric patients receiving HEN (13.75 per 1 million inhabitants) was still markedly lower compared to published data from other countries: 48.23 cases per 1 million in some regions of Italy \[[@CR15]\] and 95.6 per 1 million in the United Kingdom \[[@CR1]\]. It should be remembered, however, that 2010 corresponded to already the fourth year of pediatric HEN reimbursement/availability in Poland. One can assume this as one potential reason for both relatively low prevalence of HEN services and dynamic increase in prescription rates of enteral feeding.

Another important finding of this study is uneven geographic distribution of HEN administration rates. Home enteral nutrition was not prescribed to children living in two out of 16 provinces, probably due to the lack of centers offering HEN services in these administrative regions of Poland. In another five provinces, the rates of HEN administration were lower than three per 1 million inhabitants. However, there were several provinces where markedly higher HEN administration rates (above 15 per 1 million inhabitants) were reported. Similar regional differences in HEN distribution in children were previously reported from Spain and Italy \[[@CR3], [@CR15]\]. One should confer this highly variable HEN administration rates in Poland to the prevalence rates of pediatric disorders that usually require enteral nutrition in respective regions. Any discrepancies between these two measures would suggest potential regional deficiency of HEN services and eventually substantiate funding new pediatric centers.

Our survey documented that neurologic disorders constituted principle indication for enteral nutrition in Polish children (64.2%). Also, in other European countries, chronic neurologic disorders predominate among indications for HEN, but the fractions of pediatric patients receiving this treatment modality due to neurological reasons are lower: 28.23% in Spain \[[@CR7]\], 35% in France \[[@CR4]\], and 50% in Italy \[[@CR15]\]. Interestingly, 11-year retrospective analysis by Daveluy et al. \[[@CR5]\] revealed substantial change in the distribution of indications for HEN administered in French children. In 2000, chronic neurologic disorders constituted the most frequent indication for HEN, in contrast to 1989 when enteral nutrition was usually prescribed due to primary alimentary disorders \[[@CR5]\].

Compared to other European countries, our study revealed markedly lower percentage of pediatric patients who received HEN due to respiratory and circulatory tract disorders, and chronic kidney or liver failure. Perhaps this underrepresentation of indications other than neurological and alimentary disorders resulted from recent educational activities of the Polish Society for Clinical Nutrition of Children. During our certified courses, we focused on prescribing HEN in chronic neurological and alimentary conditions. The results of this study suggest, however, that during future courses provided by the Society more attention should be paid to other disorders that may potentially require enteral nutrition.

Recent evidence suggests that cystic fibrosis is a condition which definitely can benefit from enteral nutrition \[[@CR6], [@CR10], [@CR12], [@CR16], [@CR17]\]. In one study, cystic fibrosis patients corresponded to 23% of pediatric patients receiving enteral nutrition in France \[[@CR4]\]. In contrast, our survey revealed only 20 (3.6%) cystic fibrosis cases among children who were offered HEN in 2010. Taking into account rough estimates of cystic fibrosis prevalence in Poland (*n* = 1,500), enteral nutrition was prescribed to only 1.3% of this group, hence to six-fold lower fraction compared to tube-feed cystic fibrosis cases managed in the United States.
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